Search

Search results

374 results found

Depression in Parkinson’s Disease. CNS Drugs 2000;17;593-600.

Publication: Journal Article

Zesiewicz, TA, and RA Hauser. 2000. “Depression in Parkinson’s Disease. CNS Drugs 2000;17;593-600.”. CNS Drugs.

Modafinil treatment of pramipexole associated somnolence. Movement Disorders 2000;15:1269-1271.

Publication: Journal Article

Hauser, RA, MN Wahba, TA Zesiewicz, and WM Anderson. 2000. “Modafinil Treatment of Pramipexole Associated Somnolence. Movement Disorders 2000;15:1269-1271.”. Movement Disorders.

Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson’s disease. Movement Disorders 1998;13:383-393.

Publication: Journal Article

Kordower, JH, TB Freeman, EY Chen, EJ Mufson, PR Sanberg, RA Hauser, B Snow, and CW Olanow. 1998. “Fetal Nigral Grafts Survive and Mediate Clinical Benefit in a Patient With Parkinson’s Disease. Movement Disorders 1998;13:383-393.”. Movement Disorders.

Ropinirole for the treatment of early Parkinson’s disease: a 12-month experience. Arch Neurol 1998;55:1211-1216.

Publication: Journal Article

Sethi, KD, CF O’Brien, JP Hammerstad, CH Adler, TL Davis, RL Taylor, J Sanchez-Ramos, JM Bertoni, and RA Hauser. 1998. “Ropinirole for the Treatment of Early Parkinson’s Disease: A 12-Month Experience. Arch Neurol 1998;55:1211-1216.”. Arch Neurol.

The long-term safety and efficacy of pramipexole in advanced Parkinson’s disease. Parkinsonism and Related Disorders 2001;7(2)115-120.

Publication: Journal Article

Weiner, WJ, SA Factor, J Jankovic, RA Hauser, JW Tetrud, CH Waters, LM Shulman, and . 2001. “The Long-Term Safety and Efficacy of Pramipexole in Advanced Parkinson’s Disease. Parkinsonism and Related Disorders 2001;7(2)115-120.”. Parkinsonism and Related Disorders.

USF Parkinson's Disease and Movement Disorders Center

Parkinson’s disease, clinical trials, treatment, evaluation, Robert Hauser, Botox, Movement Disorder, tremor, cervical dystonia, blepharospasm, hemifacial spasm

Robert Hauser, MD, MBA

Person: Principal Investigator, Physician, Director of Clinical Operations

Dr. Hauser is a Professor of Neurology, Molecular Pharmacology, and Physiology at the University Of South Florida Morsani College Of Medicine, in Tampa. He serves as Director of the Clinical Signature Interdisciplinary Program in Neuroscience and as Director of the USF Health Byrd Parkinson's...

Jennifer Koebert, MPAS, MPH, PA-C

Person: Sub-Investigator, Physician Assistant

Jen graduated with a Master’s degree in Physician Assistant Studies from Elon University in 2020, and also earned her Master’s degree in Public Health from the University of Florida in 2014. She has been working with Dr. Hauser at USF as a Physician Assistant since 2020, and previously worked as a...

Erica Botting, BS, CRA-USF/Advanced

Person: Research Site Manager, Office Manager, Senior Clinical Research Associate

Erica Botting is the Research Site Manager and Senior Clinical Research Associate at the prestigious USF Parkinson's Disease and Movement Disorders Center. With a Bachelor of Science in Biology from USF, she returned to her alma mater in 2021 to take on this vital role. Erica boasts an impressive...

Deutetrabenazine Provides Long-Term Benefit for Tardive Dyskinesia Regardless of Underlying Condition and Dopamine Receptor Antagonist Use: A Post Hoc Analysis of the 3-Year, Open-Label Extension Study.

Publication: Journal Article

Hauser, RA, H Barkay, HH Fernandez, J Jimenez-Shahed, SA Factor, N Gross, L Marinelli, et al. 2024. “Deutetrabenazine Provides Long-Term Benefit for Tardive Dyskinesia Regardless of Underlying Condition and Dopamine Receptor Antagonist Use: A Post Hoc Analysis of the 3-Year, Open-Label Extension Study.”. J Clin Psychopharmacol. 2024 Jul-Aug 01;44(4):386-396. Doi: 10.1097/JCP.0000000000001885. Epub 2024 Jun 21.PMID: 38901008.